Table 1.
Important enzymatic, non-enzymatic, and synthetic antioxidants.
Antioxidants | Type of Antioxidants | Type of Antioxidants | Action Mechanism | Reference |
---|---|---|---|---|
Enzymatic | endogenous | Superoxide dismutase | Preventing peroxynitrite formation, reducing levels of F2-isoprostanes and isofurans in the aorta and reduction of transition-metal ions | [23,47] |
Catalase | Reducing vascular smooth muscle cell (VSMC) proliferation | [48,49] | ||
Glutathione peroxidase | Inhibition of H2O2-mediated expression of MCP-1 and VCAM-1 | [10,50] | ||
Thioredoxin reductase | Increasing NO bioavailability and decreasing oxidative stress | [51,52,53] | ||
Non-enzymatic | endogenous | Glutathione | Modulation of the size of atherosclerotic lesions in the aortic arch | [54] |
Uric acid | Increasing cytokine production, scavenging OH, plaque instability, attenuating endothelial activation and SMC proliferation | [68] | ||
Bilirubin | Scavenging oxidants, inhibiting protein oxidation, attenuating endothelial activation/dysfunction and SMC proliferation | [61,62,63,64,65] | ||
Coenzyme Q | Inhibiting lipid and protein oxidation, scavenging peroxyl radicals and improving endothelial function | [56,57,58,59,60] | ||
Lipoic acid | Inhibition atherosclerotic lesion development, increasing in eNOS activity | [69,70,71,72] | ||
exogenous | Vitamin E | Preventing foam cell formation and endothelial dysfunction, scavenging free radicals, diminishing the oxidation of LDL and modulating endothelial cells | [73,74,75,76,77,78,79,80,81,82] | |
Vitamin C | Enhancement of NOS activity, inhibition of cyclooxygenase, diminishing cell–cell adhesion, improvement of endothelial dysfunction and vasodilation | [87,88,89] | ||
B vitamins | Scavenging hydroxyl and lipid peroxyl radicals, improving endothelial function | [94,95] | ||
Vitamin A and Carotenoids | Prevention LDL peroxidation, reducing inflammation, oxidative stress, and endothelial dysfunction | [99,100] | ||
Polyphenols | Suppressing ROS formation, increasing the expression level of eNOS, inhibiting angiogenesis, reducing platelet aggregation and hypertension | [105,106,107,108,109,110] | ||
Synthetic | Synthetic | Probucol | Augmentation of endothelial function and repair, inducing heme oxygenase-1 (HO-1) in arterial cells, inhibiting vasomotor dysfunction and fatty streak formation, inducing heme oxygenase-1 (HO-1) in arterial cells | [87,116,117] |
BO-653n | Reduces α-tocopheroxyl radical and inhibits LDL oxidation in the intimal area | [116,117,118,119] |